HK1095146A1 - Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof - Google Patents

Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof

Info

Publication number
HK1095146A1
HK1095146A1 HK07102609.2A HK07102609A HK1095146A1 HK 1095146 A1 HK1095146 A1 HK 1095146A1 HK 07102609 A HK07102609 A HK 07102609A HK 1095146 A1 HK1095146 A1 HK 1095146A1
Authority
HK
Hong Kong
Prior art keywords
salts
preparation
pharmaceutical use
aminopyrimidine compounds
aminopyrimidine
Prior art date
Application number
HK07102609.2A
Other languages
English (en)
Inventor
Piaoyang Sun
Aifeng Lv
Baohai Yang
Chunyong Hu
Original Assignee
Piaoyang Sun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piaoyang Sun filed Critical Piaoyang Sun
Publication of HK1095146A1 publication Critical patent/HK1095146A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK07102609.2A 2004-12-31 2007-03-09 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof HK1095146A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200410103077 2004-12-31
CNA2005101074022A CN1939910A (zh) 2004-12-31 2005-09-30 氨基嘧啶类化合物及其盐和其制备方法与药物用途
PCT/CN2005/002308 WO2006069525A1 (fr) 2004-12-31 2005-12-26 Composes d’aminopyrimidine et leurs sels, procede pour la preparation et l’utilisation pharmaceutique de ceux-ci

Publications (1)

Publication Number Publication Date
HK1095146A1 true HK1095146A1 (en) 2007-04-27

Family

ID=36614492

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07102609.2A HK1095146A1 (en) 2004-12-31 2007-03-09 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof

Country Status (8)

Country Link
US (1) US8183242B2 (es)
EP (1) EP1840122B1 (es)
JP (1) JP4698681B2 (es)
CN (1) CN1939910A (es)
CA (1) CA2602738C (es)
ES (1) ES2436758T3 (es)
HK (1) HK1095146A1 (es)
WO (1) WO2006069525A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
JP5710251B2 (ja) 2007-06-07 2015-04-30 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規ヘテロ環化合物およびその使用
ES2607794T3 (es) * 2007-06-07 2017-04-04 Intra-Cellular Therapies, Inc. Compuestos heterocíclicos novedosos y usos de los mismos
EP2512246B1 (en) * 2009-12-17 2015-09-30 Merck Sharp & Dohme Corp. Aminopyrimidines as syk inhibitors
CN102796079B (zh) * 2011-05-27 2016-06-29 江苏豪森药业集团有限公司 一种甲磺酸氟马替尼的制备方法
CN102816147B (zh) * 2011-06-09 2016-06-08 江苏豪森药业集团有限公司 甲磺酸氟马替尼晶型b及其制备方法和用途
CN102816146A (zh) * 2011-06-10 2012-12-12 江苏豪森医药集团连云港宏创医药有限公司 甲磺酸氟马替尼晶型a及其制备方法和用途
CN103709147A (zh) * 2012-10-09 2014-04-09 江苏豪森医药集团连云港宏创医药有限公司 甲磺酸氟马替尼晶型及其制备方法和用途
CN103360366B (zh) * 2013-07-26 2015-04-01 天津禾盛医药技术开发有限公司 N-(5-硝基-2-甲基吡啶基-3-)-4-(3-吡啶基)-2-嘧啶胺及其中间体的制备方法
CN103396395B (zh) * 2013-07-26 2014-09-03 天津法莫西医药科技有限公司 一种合成n-（5-硝基-2-甲基吡啶基-3-）-4-（3-吡啶基）-2-嘧啶胺及其中间体的方法
CN105884746B (zh) * 2016-05-05 2018-09-21 江苏豪森药业集团有限公司 氟马替尼的合成方法
CN107652269A (zh) * 2016-07-26 2018-02-02 江苏豪森药业集团有限公司 甲磺酸氟马替尼中间体纯化方法
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
CN109438365B (zh) * 2018-12-06 2022-04-05 华南师范大学 N-(3-((4-三氟甲基)-2-嘧啶基)氨基苯基)-2,6-二氟苯磺酰胺衍生物
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
US11472791B2 (en) 2019-03-05 2022-10-18 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
WO2021030537A1 (en) 2019-08-14 2021-02-18 Incyte Corporation Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors
PE20221905A1 (es) 2019-10-11 2022-12-23 Incyte Corp Aminas biciclicas como inhibidoras de la cdk2
CN111072636B (zh) * 2019-12-16 2022-08-23 江苏豪森药业集团有限公司 氟马替尼的合成方法
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
WO2023081923A1 (en) 2021-11-08 2023-05-11 Frequency Therapeutics, Inc. Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043531A (zh) 1988-12-12 1990-07-04 衡阳市动力配件厂 合金铸铁气缸套
TW225528B (es) * 1992-04-03 1994-06-21 Ciba Geigy Ag
GB9610044D0 (en) 1996-05-14 1996-07-17 Sandoz Ltd Improvements in or relating to organic compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0022438D0 (en) * 2000-09-13 2000-11-01 Novartis Ag Organic Compounds
JP2005500261A (ja) * 2001-04-10 2005-01-06 バーテックス　ファーマシューティカルズ　インコーポレイテッド Ｓｒｃおよび他のプロテインキナーゼのインヒビターとしてのイソキサゾール誘導体
CA2446864C (en) * 2001-05-16 2011-02-15 Vertex Pharmaceuticals Incorporated Inhibitors of src and other protein kinases
ATE432929T1 (de) * 2001-06-15 2009-06-15 Vertex Pharma 5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
US7288547B2 (en) * 2002-03-11 2007-10-30 Schering Ag CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
MXPA05013349A (es) * 2003-06-13 2006-03-09 Novartis Ag Derivados de 2-amino-pirimidina como inhibidores de quinasa raf.

Also Published As

Publication number Publication date
JP2008526692A (ja) 2008-07-24
EP1840122B1 (en) 2013-08-28
EP1840122A4 (en) 2011-03-09
ES2436758T3 (es) 2014-01-07
JP4698681B2 (ja) 2011-06-08
US20080312251A1 (en) 2008-12-18
CA2602738C (en) 2011-12-20
CA2602738A1 (en) 2006-07-06
CN1939910A (zh) 2007-04-04
EP1840122A1 (en) 2007-10-03
WO2006069525A1 (fr) 2006-07-06
US8183242B2 (en) 2012-05-22

Similar Documents

Publication Publication Date Title
HK1095146A1 (en) Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
ZA200903160B (en) Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals
IL182121A0 (en) Pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containingthe same
HUP0400405A3 (en) Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
EP1731183A4 (en) SOLID PHARMACEUTICAL PREPARATION FOR DIALYSIS
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
EP1922309A4 (en) N-PHENYL-2-PYRIMDINAMINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
ZA200702596B (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
IL187235A0 (en) 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
EP1753405A4 (en) SLOW RELEASE PHARMACEUTICAL PREPARATION
SI2020410T1 (sl) Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
IL186062A (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
ZA200803152B (en) Oramucosal pharmaceutical dosage form
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
HUP0401524A2 (en) New benzoyl urea derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: DELETION OF INVENTOR:

Free format text: DELETION OF INVENTOR: CORRECTION OF THE CHINESE NAME OF THE INVENTOR FROM